Free Trial

Sutro Biopharma (STRO) SEC Filings & 10K Form

Sutro Biopharma logo
$0.92 +0.02 (+1.93%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$0.91 -0.01 (-1.52%)
As of 05/23/2025 06:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Sutro Biopharma SEC Filings

DateFilerForm TypeView
05/15/2025
10:39 AM
Kynam Capital Management, LP (Filed by)
Sutro Biopharma (Subject)
Form SCHEDULE 13G
05/08/2025
3:28 PM
Sutro Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
3:30 PM
Sutro Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/05/2025
4:45 PM
Borgman Anne Elizabeth (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
4:46 PM
Srinivasan Venkatesh (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
4:48 PM
FITZPATRICK LINDA A (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/25/2025
3:30 PM
Sutro Biopharma (Filer)
Form DEF 14A
04/25/2025
3:33 PM
Sutro Biopharma (Filer)
Form DEFA14A
04/25/2025
3:33 PM
Sutro Biopharma (Filer)
Form ARS
04/17/2025
8:35 AM
BlackRock, Inc. (Filed by)
Sutro Biopharma (Subject)
Form SCHEDULE 13G/A
04/08/2025
3:03 PM
Pauling David (Reporting)
Sutro Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/08/2025
3:05 PM
Pauling David (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2025
3:07 PM
Srinivasan Venkatesh (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2025
3:09 PM
Leyman Barbara (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2025
3:11 PM
Gerber Hans-Peter (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2025
3:12 PM
Chung Jane (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2025
3:32 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Sutro Biopharma (Subject)
Form SCHEDULE 13G
03/13/2025
4:14 PM
Sutro Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2025
4:17 PM
Sutro Biopharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/07/2025
3:14 PM
NEWELL WILLIAM J (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:06 PM
Chung Jane (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:09 PM
NEWELL WILLIAM J (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:12 PM
FITZPATRICK LINDA A (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
5:32 PM
NEWELL WILLIAM J (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
5:34 PM
Gerber Hans-Peter (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
5:40 PM
FITZPATRICK LINDA A (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
5:42 PM
Chung Jane (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
5:44 PM
ALBINI EDWARD C (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:57 PM
Borgman Anne Elizabeth (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:58 PM
Srinivasan Venkatesh (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
3:30 PM
Sutro Biopharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/10/2024
7:00 AM
Sutro Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
6:54 PM
Point72 Asset Management, L.P. (Filed by)
Sutro Biopharma (Subject)
Form SC 13G/A
11/13/2024
3:30 PM
Rubric Capital Management LP (Filed by)
Sutro Biopharma (Subject)
Form SC 13G/A
11/13/2024
3:34 PM
Sutro Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2024
8:34 AM
Adage Capital Management, L.P. (Filed by)
Sutro Biopharma (Subject)
Form SC 13G/A
11/04/2024
1:09 PM
Sutro Biopharma (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
08/13/2024
3:31 PM
Sutro Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/13/2024
3:16 PM
Chung Jane (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
3:38 PM
Jagpal Sukhi (Reporting)
Sutro Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/12/2024
3:40 PM
Jagpal Sukhi (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Market chaos is the new normal (Ad)

It happened again. Wall Street swung like a wrecking ball after Trump paused tariffs on smartphones, laptops, and semiconductors. Tech stocks surged—but not because the economy is stable. It’s because investors are panicking over trade policy whiplash. And here’s the hard truth: If your retirement is too tied to stocks, you’re exposed.

Claim your free, no-strings-attached 2025 Ultimate Guide to Gold IRAs right now.
07/10/2024
3:10 PM
Leyman Barbara (Reporting)
Sutro Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/10/2024
3:11 PM
Leyman Barbara (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:29 PM
Petree Daniel H (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:30 PM
Sutro Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2024
3:31 PM
Sutro Biopharma (Issuer)
Wigginton Jon Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:19 PM
Dybbs Michael (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:21 PM
Freund John Gordon (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:22 PM
Hunter Heidi (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:24 PM
Lobacki Joseph M (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:STRO) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners